Path Therapeutics, Inc.
www.pathbio.comPath Therapeutics' proprietary phenotypic-screening technology is uncovering new therapeutics and novel druggable targets for diseases of the central nervous system, including rare and devastating genetic forms of childhood epilepsy.
Read more
Path Therapeutics' proprietary phenotypic-screening technology is uncovering new therapeutics and novel druggable targets for diseases of the central nervous system, including rare and devastating genetic forms of childhood epilepsy.
Read more
Country
City (Headquarters)
Calgary
Industry
Employees
1-10
Founded
2014
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer , Co - Founder
Email ****** @****.comPhone (***) ****-****
Technologies
(10)
Reach decision makers at Path Therapeutics, Inc.
Free credits every month!
Path Therapeutics, Inc. FAQ
Calgary, Canada
Biotechnology Research
